• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911608300
Device Problems Occlusion Within Device (1423); Activation, Positioning or Separation Problem (2906)
Patient Problems Chest Pain (1776); Dyspnea (1816); Myocardial Infarction (1969); ST Segment Elevation (2059); Thrombosis (2100); Diaphoresis (2452)
Event Date 12/31/2016
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.(b)(4).Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) clinical study.Same case as mfr report#: 2134265-2017-00214, 2134265-2017-00216, 2134265-2017-00217.It was reported that following a coronary artery drug eluting stenting treatment procedure, myocardial infarction (mi), stent thrombosis (st), and incomplete stent apposition occurred.In (b)(6) 2012, the patient presented due to myocardial infarction and unstable angina (braunwald¿s classification) and was referred for cardiac catheterization.The de novo target lesion was located in the distal right coronary artery (dist rca) with 90% stenosis and was 22 mm long with a reference vessel diameter of 3.00 mm.The target lesion was treated with pre-dilation and placement of a 3.00 x 20 mm promus element plus stent and a 3.00 x 8 mm promus element plus stent in overlapping fashion, with 0% residual stenosis following post-dilation.The patient was discharged on aspirin and clopidogrel the next day.In (b)(6) 2016, the patient presented with chest pain associated with diaphoresis and mild shortness of breath.Subsequently the patient was referred for cardiac catheterization.One- hundred percent (100%) stent thrombosis at dist rca was noted and a samurai guidewire was placed in the vessel which resulted in distal embolization of the thrombus to the posterolateral branch.The under expansion of previously placed study stents in dist rca was then treated with balloon angioplasty and placement of a 3.5 x 16 mm synergy ii drug-eluting stent in an overlapping fashion with previously placed study stent.Following post-dilation the overlapping segment with the previously placed study stent still appeared to be under expanded.This was treated with further balloon dilation using a 4 x 15 mm quantum maverick balloon.The event was considered as resolved and the patient was discharged on dual antiplatelet therapy the next day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6290595
MDR Text Key66184851
Report Number2134265-2017-00215
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/31/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/21/2012
Device Model NumberH7493911608300
Device Catalogue Number39116-0830
Device Lot Number0014987604
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/17/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-